Successful cessation of transmitting healthcare-associated infections due to Burkholderia cepacia complex in a neonatal intensive care unit in a Japanese children's hospital

European Journal of Medical Research

Volumn 16, Issue 12, 2011, Pages 537-542

  Kuzumoto, K ^a   Kubota, N ^a   Ishii, K ^a   Yumoto, K ^a   Ogiso, Y ^a   Nakamura, T ^a   Katsuyama, T ^a   Oana, K ^b,c   Kawakami, Yoshiyuki ^b,c  

^a NAGANO CHILDREN'S HOSPITAL   (Japan)

^b SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Burkholderia cepacia; Disinfectant contamination; Health care associated infection; NICU; Nosocomial infection; Surveillance

Indexed keywords

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIOLOGY; BURKHOLDERIA CEPACIA COMPLEX; CLINICAL ARTICLE; DISEASE TRANSMISSION; EPIDEMIC; HOSPITAL INFECTION; HUMAN; JAPAN; NEWBORN; NEWBORN INTENSIVE CARE; PULMONARY ASPIRATION; PULSED FIELD GEL ELECTROPHORESIS; URINALYSIS; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATION; BURKHOLDERIA CEPACIA INFECTION; COLONY FORMING UNIT; CONTROLLED STUDY; HEALTHCARE ASSOCIATED INFECTION; HUMAN TISSUE; INFECTION CONTROL; JAPANESE (PEOPLE); MINIMUM INHIBITORY CONCENTRATION; PEDIATRIC HOSPITAL; RETROSPECTIVE STUDY; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA INFECTIONS; CROSS INFECTION; DISEASE OUTBREAKS; ELECTROPHORESIS, GEL, PULSED-FIELD; HOSPITALS, PEDIATRIC; HUMANS; INFANT; INFANT, NEWBORN; INFECTION CONTROL; INTENSIVE CARE UNITS, NEONATAL; JAPAN; RETROSPECTIVE STUDIES;

AMIKACIN; AZTREONAM; CEFEPIME; CEFOPERAZONE PLUS SULBACTAM; CEFOZOPRAN; CEFSULODIN; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MINOCYCLINE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PYRUVATE DEHYDROGENASE; TOBRAMYCIN;

EID: 84255167005     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Coenye T, Vandamme P, Govan JR, LiPuma JJ. Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol. 2001; 39: 3427-3436. (Pubitemid 32954480)
2. Vandamme P, Holmes B, Vancanneyt M, Coenye T, Hoste B, Coopman R, Revets H, Lauwers S, Gillis M, Kersters K, Govan JR. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int J Syst Bacteriol. 1997; 47: 1188-1200. (Pubitemid 27441251)
3. Vandamme P, Dawyndt P. Classification and identification of the Burkholderia cepacia complex: present and future. Syst Appl Microbiol. 2011; 34: 87-95.
4. Jones AM, Dodd ME, Webb AK. Burkholderia cepacia: current clinical issues, environmental controversies and ethical dilemmas. Eur Respir J. 2010; 17: 295-301.
5. Webb AK, Egan J. Should patients infected with Burkholderia cepacia undergo lung transplantation. Thorax 1997; 52: 671-673. (Pubitemid 27404978)
6. Snell GI, de Hoyos A, Krajden M, Winton T, Maurer JR. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis. Chest 1993; 103: 466-471. (Pubitemid 23070746)
7. Thomassen MJ, Demko CA, Klinger JD, Stern RC. Pseudomonas cepacia colonisation among patients with cystic fibrosis. A new opportunist. Am Rev Resp Dis. 1985; 131: 791-796. (Pubitemid 15066870)
8. LiPuma JJ, Dansen SE, Nielson DW, Stern RC, Stull TL. Person-to-person transmission of Pseudomonas cepacia between patients with CF. Lancet. 1990; 336: 1094-1096.
9. Loukil C, Saizou C, Doit C, Bidet P, Mariani-Kurkdjian P, Aujard Y, Beaufils F, Bingen E. Epidemiological investigation of Burkholderia cepacia acquisition in two pediatric intensive care unit. Infect Control Hosp Epidemiol. 2003; 24: 707-710. (Pubitemid 37221344)
10. Dizbay M, Tunccan OG, Sezer BE, Aktas F, Arman D. Nosocomial Burkholderia cepacia infections in a Turkish university hospital: a five-year surveillance. J Infect Dev Ctries. 2009; 3: 273-277.
11. Jones AM, Dodd ME, Webb AK. Burkholderia cepacia as a cause of ecthyma gangrenosum-like lesion. Infection 2001; 36: 271-273.
12. Mahenthiralingam E, Urban TA, Goldberg JB. The multifarious, multireplicon Burkholderia cepacia complex. Nat Rev Microbiol. 2005; 3: 144-156. (Pubitemid 40207595)
13. Oana K, Kawakami Y, Hayashi T, Ohnishi M. Simple broad-spectrum protocol using labiase for bacterial cell lysis to prepare genomic DNA for pulsed-field gel electrophoresis analysis. Microbiol Immunol. 2009; 53: 45-48.
14. Oana K, Kawakami Y, Ohnishi M, Ishikawa M, Hirota M, Tozuka M, Atarashi K, Baba K, Fujiki K, Okazaki M, Honda T, Hayashi T. Molecular and epidemiological study of the first outbreak of vanB type vancomycin-resistant Enterococcus faecalis in Japan. Jpn J Infect Dis. 2001; 54: 17-22. (Pubitemid 32499511)
15. Coenye T, Spilker T, Martin A, LiPuma JJ. Comparative assessment of genotyping methods for epidemiologic study of Burkholderia cepacia genomovar III. J Clin Microbiol. 2001; 40: 3300-3307. (Pubitemid 34977445)
16. Hutchinson GR, Parker S, Pryor JA, Duncan-Skingle F, Hoffman PN, Hodson ME, Kaufmann ME, Pitt TL. Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis. J Clin Microbiol. 1996; 34: 584-587. (Pubitemid 26065780)
17. Saiman L, Siegel J. Infection control in cystic fibrosis. Clin Microbiol Rev. 2004; 17: 57-71. (Pubitemid 38120929)
18. Hakuno H, Yamamoto M, Oie S, Kamiya A. Microbial contamination of disinfectants used for intermittent self-catheterization. Jpn J Infect Dis. 2010; 63: 277-279.
19. Dawson SJ. The role of the infection control link nurse. J Hosp Infect. 2003; 54: 251-257. (Pubitemid 37554919)
20. Teare EL, Peacock A. The development of an infection control link-nurse programme in a district general hospital. J Hosp Infect. 1996; 34: 267-278. (Pubitemid 27007391)